TFPI2 and Hyperglycemia: In cardiovascular diseases, previous studies have indicated that TFPI2 can inhibit hyperglycaemia-induced vascular smooth muscle cell (VSMC) migration and neointimal hyperplasia by inhibiting the expression and activity of MMPs [17, 29].